ASRT
Assertio Therapeutics Inc
NASDAQ: ASRT · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$18.43
+2.11% today
Updated 2026-04-30
Market cap
$118.97M
P/E ratio
—
P/S ratio
1.00x
EPS (TTM)
$-4.74
Dividend yield
—
52W range
$9 – $20
Volume
0.2M
Assertio Therapeutics Inc (ASRT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $66.38M | $52.62M | $80.64M | $95.08M | $91.58M | $87.03M | $164.37M | $141.65M | $508.65M | $711.07M | $1.36B | $1.23B | $1.04B | $932.87M | $527.17M | $303.27M | $326.55M | $413.91M | $286.42M | $284.73M |
| Cash & equivalents | $7.57M | $14.57M | $14.37M | $22.13M | $26.82M | $22.53M | $24.04M | $77.89M | $276.02M | $566.40M | $209.77M | $177.42M | $128.09M | $110.95M | $42.11M | $20.79M | $36.81M | $64.94M | $73.44M | $50.59M |
| Current assets | $63.00M | $47.88M | $62.77M | $93.99M | $78.43M | $79.60M | $109.49M | $108.34M | $314.59M | $622.05M | $316.65M | $307.66M | $231.72M | $215.92M | $103.95M | $94.25M | $103.50M | $132.26M | $171.06M | $202.55M |
| Total liabilities | $59.62M | $79.91M | $35.13M | $61.93M | $75.86M | $63.92M | $58.45M | $57.72M | $371.24M | $346.62M | $1.05B | $974.55M | $869.11M | $712.53M | $469.21M | $247.76M | $224.13M | $188.19M | $148.42M | $163.65M |
| Current liabilities | $8.07M | $22.34M | $14.33M | $22.38M | $32.20M | $32.98M | $39.84M | $51.37M | $119.23M | $52.69M | $196.79M | $221.77M | $224.40M | $124.90M | $184.55M | $132.69M | $135.02M | $95.32M | $93.44M | $114.69M |
| Long-term debt | — | — | — | $5.78M | $2.17M | — | $0.00 | $0.00 | $0.00 | $229.89M | $806.51M | $718.78M | $544.23M | $446.11M | $271.26M | $72.16M | $61.32M | $66.40M | $38.21M | $38.65M |
| Shareholder equity | $6.76M | $-27.29M | $45.52M | $33.15M | $15.73M | $23.11M | $105.92M | $83.94M | $137.42M | $364.45M | $315.06M | $250.79M | $169.51M | $220.34M | $57.96M | $55.51M | $102.41M | $225.72M | $138.00M | $121.08M |
| Retained earnings | $-144.45M | $-184.11M | $-134.89M | $150.19M | $-172.20M | $-168.31M | $-97.58M | $-127.36M | $-84.05M | $47.71M | $-28.02M | $-116.74M | $-219.51M | $-182.60M | $-399.80M | $-427.94M | $-429.23M | $-319.60M | $-651.54M | $-673.12M |
| Accounts receivable | $1.96M | $9.08M | $3.62M | $3.67M | $4.93M | $6.35M | $12.55M | $13.69M | $22.27M | $32.11M | $78.05M | $102.59M | $72.48M | $37.21M | $42.74M | $44.35M | $43.75M | $45.36M | $47.66M | $54.12M |
| Inventory | $864786.00 | $4.48M | $3.26M | $2.85M | $2.56M | $1.57M | $5.39M | $9.59M | $10.14M | $8.46M | $10.49M | $13.03M | $13.04M | $3.40M | $3.41M | $11.71M | $7.49M | $13.70M | $37.69M | $38.31M |
| Goodwill | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |